Clinical and Hematological Relevance of JAK2V617F, CALR, and MPL Mutations in Vietnamese Patients with Essential Thrombocythemia

Volume 20, Issue 9, September 2019, Pages 2775-2780

Hoang Anh Vu; Tran Thi Thao; Cao Van Dong; Nguyen Lam Vuong; Ho Quoc Chuong; Phan Nguyen Thanh Van; Huynh Nghia; Nguyen Tan Binh; Phu Chi Dung; Phan Thi Xinh

• View Article
• PDF 404.42 K

Platelet Function Tests and Inflammatory Markers for the Differentiation of Primary Thrombocytosis and Secondary Thrombocytosis

Volume 20, Issue 7, July 2019, Pages 2079-2085

Piyapong Kanya; Ekarat Rattarittamrong; Ornkamon Wongtakan; Thanawat Rattanathammethee; Chatree Chai-Adisaksopha; Adisak Tantiworawit; Lalita Norrasethada

• View Article
• PDF 308.88 K

Clinical Manifestations and Risk Factors for Complications of Philadelphia Chromosome-Negative Myeloproliferative Neoplasms

Volume 16, Issue 12, December 2015, Pages 5013-5018

• View Article
• PDF 475.35 K

Clinico-Hematological Profile and Risk Stratification in Patients with Essential Thrombocythemia: Experience from Pakistan

Volume 16, Issue 17, December 2015, Pages 7659-7661

• View Article
• PDF 350.01 K

Acquired JAK-2 V617F Mutational Analysis in Pakistani Patients with Essential Thrombocythemia

Volume 16, Issue 16, December 2015, Pages 7327-7330

• View Article
• PDF 327.04 K